Suppression of A549 lung cancer cell migration by precursor let-7g microRNA

Molecular Medicine Reports

Volumn 3, Issue 6, 2010, Pages 1007-1013

  Park, Sungjin ^a   Minai Tehrani, Arash ^a   Xu, Cheng Xiong ^a   Chang, Seung Hee ^a   Woo, Min Ah ^a,b   Noh, Mi Suk ^a,b   Lee, Eun Sun ^a   Lim, Hwang Tae ^a,b   An, Gil Hwan ^c   Lee, Kee Ho ^d   Sung, Ha Jung ^e   Beck Jr , George R ^f   Cho, Myung Haing ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Chungnam National University   (South Korea)

^d Korea Institute of Radiation and Medical Science   (South Korea)

^e Hoseo University   (South Korea)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Let 7g; Lung cancer cell migration; microRNA

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; K RAS PROTEIN; MICRORNA; PRECURSOR MICRORNA LET 7G; RNA PRECURSOR; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER;

EID: 78649479378     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.373     Document Type: Article

References (32)

1. Bartel D: MicroRNA genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
3. Filipowicz W, Bhattacharyya S and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
4. Bussing I, Slack F and Grosshans H: let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14: 400-409, 2008.
5. Lewis B, Burge C and Bartel D: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
6. Lewis B, Shih I, Jones-Rhoades M, Bartel D and Burge C: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003.
7. Kumar M, Erkeland S, Pester R, et al: Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908, 2008.
8. Calin G, Sevignani C, Dumitru C, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
9. Johnson S, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
10. Park S, Shell S, Radjabi A, et al: Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6: 2585-2590, 2007.
11. Jiang J, Lee E, Gusev Y and Schmittgen T: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005.
12. Suzuki H, Yamagata K, Sugimoto K, Iwamoto T, Kato S and Miyazono K: Modulation of microRNA processing by p53. Nature 460: 529-533, 2009.
13. Xi Y, Shalgi R Fodstad O, Pilpel Y and Ju J: Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12: 2014-2024, 2006.
14. Fedele M, Battista S, Manfioletti G, Croce C, Giancotti V and Fusco A: Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22: 1583-1591, 2001.
15. Fedele M, Visone R, De Martino I, et al: HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9: 459-471, 2006.
16. Tarasov V, Jung P, Verdoodt B, et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing. Cell Cycle 6: 1586-1593, 2007.
17. Johnson C, Esquela-Kerscher A, Stefani G, et al: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722, 2007.
18. Di Cello F, Hillion J, Hristov A, et al: HMGA2 participates in transformation in human lung cancer. Mol Cancer Res 6: 743-750, 2008.
19. Meyer B, Loeschke S, Schultze A, et al: HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 46: 503-511, 2007.
20. Sarhadi V, Wikman H, Salmenkivi K, et al: Increased expression of high mobility group A proteins in lung cancer. J Pathol 209: 206-212, 2006.
21. Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y and Nakao M: HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am J Pathol 174: 854-868, 2009.
22. D'Souza S, Vespa A, Murkherjee S, Maher A, Pajak A and Dagnino L: E2F-1 is essential for normal epidermal wound repair. J Biol Chem 277: 10626-10632, 2002.
23. Yu F, Yao H, Zhu P, et al: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123, 2007.
24. Nishino J, Kim I, Chada K and Morrison S: Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135: 227-239, 2008.
25. Esquela-Kerscher A, Trang P, Wiggins J, et al: The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764, 2008.
26. Jakymiw A, Patel R, Deming N, et al: Overexpression of dicer as a result of reduced let-7 microRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 49: 549-559, 2010.
27. Schultz J, Lorenz P, Gross G, Ibrahim S and Kunz M: MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18: 549-557, 2008.
28. Legesse-Miller A, Elemento O, Pfau S, Forman J, Tavazoie S and Coller H: let-7 overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts. J Biol Chem 284: 6605-6609, 2009.
29. Shimizu S, Takehara T, Hikita H, et al: The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 52: 698-704, 2010.
30. Jeong S, Wu H and Park W: LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 41: 912-918, 2009.
31. Wagner-Ecker M, Schwager C, Wirkner U, Abdollahi A and Huber P: MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol 5: 25-34, 2010.
32. Ji J, Zhao L, Budhu A, et al: Let-7g targets collagen type I (alpha) 2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52: 690-697, 2010.